Completed
Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)
NCT04145440
- Conditions
- Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- North America Research Institute Azusa, California, United States
- UCSF Medical Center San Francisco, California, United States
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance, California, United States
- University of Miami Division of Nephrology & Hypertension Miami, Florida, United States